semaglutide pediatric dosing Wegovyยฎโฝ (semaglutide injection) for cardiovascular risk reduction ๐จ FDA Approval Alert ๐จ
Description
Feng P, Zhang X, Li D, et al
N Engl J Med 2022;387(9):852854
Br J Cancer
doi: 10.1210/en.2016-1038
Storage Instructions Controlled room temperature (per investigational protocol) Protect from excessive moisture and heat No refrigeration needed for oral solid formulations Keep in original container until use Important Clinical Context Tesofensine has not been approved by the FDA for obesity treatment
When used with insulin or sulfonylureas, these medications may increase hypoglycemia risk, requiring dose adjustments of those agents
